Boston Bio Systems Limited has announced a board meeting to consider and approve the audited financial results for the quarter and year ended March 31, 2025. The meeting will also address other business matters as needed. The trading window for directors, officers, and designated employees remains closed from April 1, 2025, until 48 hours after the results are declared, ensuring compliance with insider trading policies. This update highlights upcoming financial disclosures important for shareholders anticipating the company’s performance.